AgraFlora Organics has sold its rights to AgraLeaf SA in Greece in exchange for common shares of Roughrider, valued at 150% of AgraFlora's original investment in the Greek venture. AgraFlora anticipates it will own approximately 8% of the common shares of Roughrider after the closing of the transaction. Further, AgraFlora intends to enter into a supply agreement with Roughrider's Greek pharmaceutical partner to purchase cannabis flower and oils for its pharmaceutical products. The agreement will also extend to AgraFlora genetics and technical support.
"Our new strategic relationship with Roughrider Capital and its European partners is a tremendous opportunity for AgraFlora to supply the world's second largest cannabis market: the European Union," said Derek Ivany, President & CEO, AgraFlora Organics. "The sale of our ownership in AgraLeaf SA allows our management team to focus solely on our Canadian operations and bringing the first phase of the Delta Greenhouse Complex online, which is projected for the third quarter of 2019. A supply agreement with Roughrider's partners in Greece will provide access to the Greek and ultimately EU cannabis markets for our high-quality cannabis flower and oils. We also envision extending our relationship by participating with Roughrider and its European partners in clinical studies on the use of cannabinoids for the reduction of high blood pressure and anxiety."
AgraFlora announced in September 2018 its intention to enter the European markets through an investment in Greece and on April 3, 2019 the company announced its intention to create a Greek company with Liberty Leaf named AgraLeaf SA to gain entry into the medical cannabis market in the European Union. AgraFlora has established a team in Greece consisting of personnel with expertise in commercial horticulture, government affairs, legal and finance. Liberty Leaf has also agreed to sell its interest in AgraLeaf SA to Roughrider.
For more information:
AgraFlora Organics
agraflora.com